(Q50129705)

25 February 2018

review article

1 reference

title

Potential and limitations of polysaccharide vaccines in infancy. (English)

1 reference

25 February 2018

1 reference

1 reference

Cadoz M

1

1 reference

25 February 2018

language of work or name

English

0 references

publication date

1 August 1998

1 reference

25 February 2018

published in

Vaccine

1 reference

25 February 2018

volume

16

1 reference

25 February 2018

issue

14-15

1 reference

25 February 2018

page(s)

1391-1395

1 reference

25 February 2018

Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900097-8

7 January 2021

VARIATION AND TYPE SPECIFICITY IN THE BACTERIAL SPECIES HEMOPHILUS INFLUENZAE.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900097-8

7 January 2021

Interim Report of a Controlled Field Trial of Immunization with Capsular Polysaccharides of Haemophilus influenzae Type band Group C Neisseria meningitidis in Mecklenburg County, North Carolina (March 1974-March 1976)

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900097-8

7 January 2021

Safety and immunogenicity of a new Haemophilus influenzae type b vaccine in infants under one year of age

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900097-8

7 January 2021

Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900097-8

7 January 2021

Antibody responses to Haemophilus influenzae type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with the nontoxic protein CRM197.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900097-8

7 January 2021

Prevention of otitis media in children by pneumococcal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900097-8

7 January 2021

Use of pneumococcal vaccine for prevention of recurrent acute otitis media in infants in Boston. The Greater Boston Collaborative Otitis Media Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900097-8

7 January 2021

Pneumococcal vaccine and otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900097-8

7 January 2021

Vaccination against Streptococcus pneumoniae in childhood: lack of demonstrable benefit in young Australian children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900097-8

7 January 2021

Pneumococcal vaccine prevents death from acute lower-respiratory-tract infections in Papua New Guinean children.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900097-8

7 January 2021

Meningococcal Disease: Still with Us

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900097-8

7 January 2021

Tetravalent (A, C, Y, W 135) meningococcal vaccine in children: immunogenicity and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900097-8

7 January 2021

Immunogenicity of group A and group C meningococcal polysaccharides in human infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900097-8

7 January 2021

Kinetics of Antibody Production to Group A and Group C Meningococcal Polysaccharide Vaccines Administered during the First Six Years of Life: Prospects for Routine Immunization of Infants and Children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900097-8

7 January 2021

Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900097-8

7 January 2021

"Love's labours lost": failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900097-8

7 January 2021

Multidrug-resistant typhoid fever in children: epidemiology and therapeutic approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900097-8

7 January 2021

Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900097-8

7 January 2021

Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900097-8

7 January 2021

Protective activity of Vi capsular polysaccharide vaccine against typhoid fever

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900097-8

7 January 2021

10.1016/S0264-410X(98)00097-8

Identifiers

DOI

1 reference

25 February 2018

1 reference

25 February 2018